The result, typically, is to identify the right combination of tweaks capable of bringing about marginal changes that, when multiplied by a huge number of instances, or allowed to work over a long time, produce a significant effect".It is about building a mountain with pebbles," says Jim Manzi, the boss of Applied Predictive Technologies, which sells data-crunching software.
Considering that tumor development is generally multifactorial, therapy with a combination of agents capable of potentiating cytotoxic effects is promising.
Using this technique, we were able to transfect fibroblasts every 24 hours with RNA encoding Oct4, Sox2, Klf4, and Utf1, a combination of factors capable of reprogramming human fibroblasts to a pluripotent stem-cell state [31] (Fig. 2D).
This therefore warrants use of a combination of techniques capable of identifying both single base mutations in addition to large genomic rearrangements.
Our working hypothesis was that FACS-QTL would allow us to isolate and characterize rare individuals that could overcome the galactose toxicity and that these individuals would possess a complex combination of alleles capable of suppressing the monogenic trait.
We conclude that a combination of techniques capable of detecting both single base mutations and small insertions / deletions and large genomic rearrangements is necessary in order to accurately analyze the BRCA1 gene in patients at high risk of carrying a germline mutation as determined by their family history.
These results identify a novel chemoresistance mechanism in ovarian cancer, and show that combination of drugs capable of suppressing MnSOD with conventional chemotherapeutic agents may provide a novel strategy with a superior therapeutic index and advantage for the treatment of refractory ovarian cancer.
The sets of substitutions required for a respiratory droplet transmissible A/H5N1 virus identified by (1) and (2) are unlikely to be the only combinations of substitutions capable of producing a respiratory droplet transmissible A/H5N1 virus.
Combinations of HDC, capable of ample cytoreduction, with novel agents that target specific tumor features responsible for post-transplant relapse may hold promise.
With several combinations of mtZFNs capable of specifically degrading targeted mtDNA variants, these data predict that the mtZFN approach could be advantageous to patients with primary mitochondrial diseases and may constitute a feasible genetic therapy approach in the future.
